COMPREHENSIVE VIRAL RESPIRATORY INFECTION DETECTION The Vivalytic multiplex Viral Respiratory Tract Infection (VRI) Array can identify SARS-CoV-2 (COVID-19) and differentiate it from other respiratory infections with similar symptoms, including influenza, RSV and all known coronaviruses. The test only requires a single nasal swab from the patient and an easy four step process to be carried out by the user. Detection Method: Randox Biochip Technology (End-Point PCR) Result Time: 2.5 Hours Sample Volume: 300µl Clinical Sample Sample Type: Nasopharyngeal or Oropharyngeal Swab VIRUS SARS-CoV-2 (COVID-19) Adenovirus A/B/C/D/E Sarbecovirus (SARS, SARS Like, SARS-CoV-2) Enterovirus A/B/C/D / Rhinovirus A/B/C Coronavirus 229E/NL63 Influenza A Coronavirus OC43/HKUI Influenza B Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Respiratory Syncytial Virus A/B (RSV)

VIVALYTIC Cartridge Based Testing Platform The new SARS-CoV-2 lollipop pooling test will be conducted on Vivalytic, a point of care platform brought to the market by Randox Laboratories and Bosch. The Vivalytic system is a fully-automated, cartridge-based platform capable of both Hi-Plex and Lo-Plex infectious disease testing. Each easy to use cartridge contains all necessary reagents, is fully-sealed to minimise risk and can be conveniently stored at room temperature. Vivalytic Key Features: • • • • • Cartridge based platform Fully-automated Suitable for both non-laboratory & laboratory settings...